Pancreatic cancer screening has advanced significantly in recent years. There are now research-based guidelines on screening ...

A new mouse study by researchers at the University of California (UC), San Diego, School of Medicine reveals that an enzyme ...

Little progress has been made on the treatment of advanced pancreatic ... cancer. The role for other anti-VEGF and EGF receptor inhibitors continues to be investigated. Not only new therapeutic ...

Pancreatic ductal adenocarcinoma remains a challenge to treat due to its complex biology and resistance mechanisms.

An enzyme called MICAL2 promotes tumor growth and metastasis in the most common form of pancreatic cancer, according to a new study.

Long before mRNA vaccines captured global attention during the COVID-19 pandemic, researchers were already exploring their ...

Michel Vulfovich, Sylvester Comprehensive Cancer ... with pancreatic cancer. The role for other anti-VEGF and EGF receptor inhibitors continues to be investigated. Not only new therapeutic agents ...

Pancreatic cancer kills 50,000 people each year, according to the National Cancer Institute, and there are few effective ...

Four oncologists from the Sarah Cannon Research Institute in Tennessee shared with Fox News Digital what they see as the most ...

Dr. Rahul S. Shinde, assistant professor in Wistar’s Ellen and Ronald Caplan Cancer Center, researches potential new therapies for treatment-resistant cancers like pancreatic cancer. In this ...